Target intelligence / Profile preview

METTL14 divergent transcript (METTL14-DT)

Target
METTL14-DT
Molecular classification
Other (Long non-coding RNA)
01

Overview

METTL14 divergent transcript (METTL14-DT) is a long non-coding RNA gene located adjacent to the METTL14 protein-coding gene[4]. Long non-coding RNAs such as METTL14-DT do not code for proteins but can regulate gene expression and chromatin structure. METTL14-DT is classified as a divergent transcript due to its orientation and position relative to METTL14. There is currently no evidence in the biomedical literature indicating that METTL14-DT itself serves as a therapeutic target (such as a receptor, enzyme, transporter, etc.), or that it is directly involved in any specific diseases or targeted by drugs. While METTL14, its protein neighbor, is well-studied as part of the m6A methyltransferase complex, METTL14-DT should not be confused with METTL14 or its protein product. Summary of findings: - METTL14-DT is distinct from METTL14 and is not itself a protein, methyltransferase, or therapeutic target. - METTL14-DT is best classified as a long non-coding RNA (lncRNA), specifically a divergent transcript[4]. - There is no evidence that METTL14-DT is druggable, targets any known pathways, or is involved in disease processes as of current data. If you were looking for information on METTL14 (the protein-coding methyltransferase), which is indeed a therapeutic target involved in RNA modification, refer to METTL14 (methyltransferase-like protein 14), not METTL14-DT.

Other names
METTL14-DT
02

Biological functions

Unknown (The specific biological functions of METTL14-DT are not clearly described in available sources; it is a non-coding RNA and may be involved in gene regulation as other divergent transcripts/lincRNAs typically are)
03

Disease associations

Unknown (As of current knowledge, no disease roles are definitively established for METTL14-DT)

Beyond the preview

Go deeper on METTL14 divergent transcript (METTL14-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on METTL14 divergent transcript (METTL14-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call